Bari Kilcoyne1, Dvora Shmulewitz2, Jacquelyn L Meyers1, Efrat Aharonovich2, Eliana Greenstein3, Amos Frisch4, Abraham Weizman5, Baruch Spivak6, Howard J Edenberg7, Joel Gelernter8, Deborah S Hasin9. 1. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. 2. Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, New York State Psychiatric Institute, New York, New York. 3. New York State Psychiatric Institute, New York, New York. 4. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Felsenstein Medical Research Center, Petach Tikva, Israel. 5. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Felsenstein Medical Research Center, Petach Tikva, Israel, Research Unit, Geha Mental Health Center, Petach Tikva, Israel. 6. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 7. Departments of Biochemistry and Molecular Biology, Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana. 8. Departments of Psychiatry, Genetics and Neurobiology, Yale University School of Medicine, New Haven, Connecticut. 9. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York, New York State Psychiatric Institute, New York, New York.
Abstract
OBJECTIVE: A single nucleotide variation in the alcohol dehydrogenase 1B (ADH1B) gene, rs1229984, produces an ADH1B enzyme with faster acetaldehyde production. This protective variant is associated with lower alcohol consumption and lower risk for alcohol use disorders (AUDs). Based on the premise that faster ADH1B kinetics decreases alcohol consumption, we formally tested if the association between ADH1B variant rs1229984 and AUDs occurs through consumption. We also tested whether the association between rs1229984 and each of the 11 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), AUD criteria occurs through consumption. METHOD: A total of 1,130 lifetime drinkers from an Israeli household sample were assessed with a structured interview and genotyped for rs1229984 (protective allele frequency = 0.28). Logistic regression evaluated the association between rs1229984 and each phenotype (AUDs, 11 individual DSM-IV criteria). For phenotypes significantly related to rs1229984, the effect through consumption was tested with logistic regression and bootstrapping. RESULTS: ADH1B rs1229984 was significantly associated with AUDs and six criteria, with odds ratios ranging from 1.32 to 1.96. The effect through consumption was significant for these relationships, explaining 23%-74% of the total ADH1B effect. CONCLUSIONS: This is the first study to show that ADH1B rs1229984 is related to 6 of the 11 DSM-IV AUD criteria and that alcohol consumption explained a significant proportion of these associations and the association of ADH1B with AUDs. Better understanding of the relationship between ADH1B and the DSM-IV AUD criteria, including effects through consumption, will enhance our understanding of the etiologic model through which AUDs can occur.
OBJECTIVE: A single nucleotide variation in the alcohol dehydrogenase 1B (ADH1B) gene, rs1229984, produces an ADH1B enzyme with faster acetaldehyde production. This protective variant is associated with lower alcohol consumption and lower risk for alcohol use disorders (AUDs). Based on the premise that faster ADH1B kinetics decreases alcohol consumption, we formally tested if the association between ADH1B variant rs1229984 and AUDs occurs through consumption. We also tested whether the association between rs1229984 and each of the 11 Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), AUD criteria occurs through consumption. METHOD: A total of 1,130 lifetime drinkers from an Israeli household sample were assessed with a structured interview and genotyped for rs1229984 (protective allele frequency = 0.28). Logistic regression evaluated the association between rs1229984 and each phenotype (AUDs, 11 individual DSM-IV criteria). For phenotypes significantly related to rs1229984, the effect through consumption was tested with logistic regression and bootstrapping. RESULTS:ADH1Brs1229984 was significantly associated with AUDs and six criteria, with odds ratios ranging from 1.32 to 1.96. The effect through consumption was significant for these relationships, explaining 23%-74% of the total ADH1B effect. CONCLUSIONS: This is the first study to show that ADH1Brs1229984 is related to 6 of the 11 DSM-IV AUD criteria and that alcohol consumption explained a significant proportion of these associations and the association of ADH1B with AUDs. Better understanding of the relationship between ADH1B and the DSM-IV AUD criteria, including effects through consumption, will enhance our understanding of the etiologic model through which AUDs can occur.
Authors: N L Saccone; J M Kwon; J Corbett; A Goate; N Rochberg; H J Edenberg; T Foroud; T K Li; H Begleiter; T Reich; J P Rice Journal: Am J Med Genet Date: 2000-10-09
Authors: Risë B Goldstein; S Patricia Chou; Sharon M Smith; Jeesun Jung; Haitao Zhang; Tulshi D Saha; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant Journal: J Stud Alcohol Drugs Date: 2015-05 Impact factor: 2.582
Authors: Dongbing Lai; Leah Wetherill; Sarah Bertelsen; Caitlin E Carey; Chella Kamarajan; Manav Kapoor; Jacquelyn L Meyers; Andrey P Anokhin; David A Bennett; Kathleen K Bucholz; Katharine K Chang; Philip L De Jager; Danielle M Dick; Victor Hesselbrock; John Kramer; Samuel Kuperman; John I Nurnberger; Towfique Raj; Marc Schuckit; Denise M Scott; Robert E Taylor; Jay Tischfield; Ahmad R Hariri; Howard J Edenberg; Arpana Agrawal; Ryan Bogdan; Bernice Porjesz; Alison M Goate; Tatiana Foroud Journal: Genes Brain Behav Date: 2019-06-04 Impact factor: 3.449
Authors: Sandra Sanchez-Roige; Abraham A Palmer; Pierre Fontanillas; Sarah L Elson; Mark J Adams; David M Howard; Howard J Edenberg; Gail Davies; Richard C Crist; Ian J Deary; Andrew M McIntosh; Toni-Kim Clarke Journal: Am J Psychiatry Date: 2018-10-19 Impact factor: 18.112